The Role of Th17 in Neuroimmune Disorders: A Target for CAM Therapy. Part III
about
Neuroantibody biomarkers: links and challenges in environmental neurodegeneration and autoimmunityAmeliorate Effects of Li-Fu Formula on IL-6-Mediated Cardiac Hypertrophy in Hamsters Fed with a Hyper-Cholesterol DietNatural product HTP screening for antibacterial (E.coli 0157:H7) and anti-inflammatory agents in (LPS from E. coli O111:B4) activated macrophages and microglial cells; focus on sepsis.Peripheral Inflammatory Markers Contributing to Comorbidities in Autism.MicroRNAs as novel regulators of neuroinflammation.Initial immunopathogenesis of multiple sclerosis: innate immune response.
P2860
The Role of Th17 in Neuroimmune Disorders: A Target for CAM Therapy. Part III
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The Role of Th17 in Neuroimmune Disorders: A Target for CAM Therapy. Part III
@ast
The Role of Th17 in Neuroimmune Disorders: A Target for CAM Therapy. Part III
@en
type
label
The Role of Th17 in Neuroimmune Disorders: A Target for CAM Therapy. Part III
@ast
The Role of Th17 in Neuroimmune Disorders: A Target for CAM Therapy. Part III
@en
prefLabel
The Role of Th17 in Neuroimmune Disorders: A Target for CAM Therapy. Part III
@ast
The Role of Th17 in Neuroimmune Disorders: A Target for CAM Therapy. Part III
@en
P2093
P2860
P356
P1476
The Role of Th17 in Neuroimmune Disorders: A Target for CAM Therapy. Part III
@en
P2093
Aristo Vojdani
Gottfried Kellermann
Jama Lambert
P2860
P304
P356
10.1093/ECAM/NEP064
P577
2011-06-16T00:00:00Z